COM:BIODESIX
Biodesix
- Stock
Last Close
1.20
22/11 21:00
Market Cap
185.79M
Beta: -
Volume Today
702.98K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|
net income | -26.17M - | -30.73M 17.43% | -31.35M 2.03% | -43.16M 37.67% | -65.45M 51.64% | -52.15M 20.32% | |
depreciation and amortization | 1.74M - | 2.79M 60.52% | 2.90M 3.94% | 3.18M 9.47% | 5.84M 83.89% | 5.51M 5.77% | |
deferred income tax | 47K - | 2.36M 4,927.66% | 1.60M 32.46% | -2.10M 231.89% | 4.04M - | ||
stock based compensation | 142K - | 170K 19.72% | 3.71M 2,081.76% | 4.94M 33.30% | 5.96M 20.57% | 5.37M 9.86% | |
change in working capital | 253K - | -1.65M 750.20% | -4.80M 191.85% | 4.59M 195.63% | -4.34M 194.62% | 11.30M 360.22% | |
accounts receivables | -146K - | -3.65M 2,397.26% | -10.31M 182.72% | 11.45M 211.12% | -1.50M 113.10% | -4.72M 214.32% | |
inventory | -389K - | 17K 104.37% | -11.65M 68,652.94% | 7.42M 163.71% | 906K 87.80% | 166K 81.68% | |
accounts payables | 342K - | 1.19M 248.83% | 11.65M 876.87% | -7.42M 163.71% | -773K 89.59% | 513K 166.36% | |
other working capital | 446K - | 791K 77.35% | 5.51M 596.21% | -6.86M 224.62% | -2.98M 56.64% | 15.34M 615.56% | |
other non cash items | 6.31M - | 5.32M 15.67% | 6.58M 23.65% | 4.33M 34.19% | 13.01M 200.69% | 3.05M 76.54% | |
net cash provided by operating activities | -17.68M - | -21.73M 22.91% | -21.37M 1.66% | -28.22M 32.09% | -44.97M 59.35% | -22.87M 49.15% | |
investments in property plant and equipment | -617K - | -1.42M 129.50% | -2.18M 53.74% | -2.55M 17.00% | -3.53M 38.75% | -23.06M 552.57% | |
acquisitions net | -456K - | -750K 64.47% | |||||
purchases of investments | |||||||
sales maturities of investments | |||||||
other investing activites | |||||||
net cash used for investing activites | -617K - | -1.87M 203.40% | -2.93M 56.36% | -2.55M 12.98% | -3.53M 38.75% | -23.06M 552.57% | |
debt repayment | -22.52M - | -13.04M 42.09% | -7.80M 40.21% | -45.43M 482.63% | -28.60M 37.03% | -9.04M 68.40% | |
common stock issued | 10.05M - | 72M 616.63% | 16.67M 76.85% | 59.54M 257.14% | 28.86M 51.53% | ||
common stock repurchased | 328K - | 355K 8.23% | 643K 81.13% | ||||
dividends paid | -328K - | -643K - | |||||
other financing activites | 41.55M - | 25.97M 37.51% | 16.93M 34.81% | 30.02M 77.33% | 27.59M 8.08% | 9.31M 66.27% | |
net cash used provided by financing activities | 19.03M - | 22.97M 20.70% | 81.13M 253.17% | 1.26M 98.44% | 58.88M 4,565.77% | 29.13M 50.53% | |
effect of forex changes on cash | -1K - | ||||||
net change in cash | 738K - | -626K 184.82% | 56.84M 9,179.55% | -29.51M 151.92% | 10.38M 135.16% | -16.80M 261.95% | |
cash at beginning of period | 5.36M - | 6.09M 13.78% | 5.47M 10.27% | 62.31M 1,039.47% | 32.80M 47.36% | 43.19M 31.68% | |
cash at end of period | 6.09M - | 5.47M 10.27% | 62.31M 1,039.47% | 32.80M 47.36% | 43.17M 31.64% | 26.38M 38.89% | |
operating cash flow | -17.68M - | -21.73M 22.91% | -21.37M 1.66% | -28.22M 32.09% | -44.97M 59.35% | -22.87M 49.15% | |
capital expenditure | -617K - | -1.42M 129.50% | -2.18M 53.74% | -2.55M 17.00% | -3.53M 38.75% | -23.06M 552.57% | |
free cash flow | -18.29M - | -23.14M 26.50% | -23.54M 1.73% | -30.77M 30.70% | -48.51M 57.64% | -45.93M 5.31% |
All numbers in (except ratios and percentages)